These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9570535)

  • 21. Highly restricted T cell repertoire shaped by a single major histocompatibility complex-peptide ligand in the presence of a single rearranged T cell receptor beta chain.
    Fukui Y; Hashimoto O; Inayoshi A; Gyotoku T; Sano T; Koga T; Gushima T; Sasazuki T
    J Exp Med; 1998 Sep; 188(5):897-907. PubMed ID: 9730891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
    Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
    Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
    Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
    Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of T-cell receptor repertoires during thymic T-cell development.
    Matsutani T; Ohmori T; Ogata M; Soga H; Yoshioka T; Suzuki R; Itoh T
    Scand J Immunol; 2006 Jul; 64(1):53-60. PubMed ID: 16784491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic control of peripheral TCRAV usage by representation in the preselection repertoire and MHC allele-specific overselection.
    Torres-Nagel N; Mehling B; LeRolle AF; Joly E; Hünig T
    Int Immunol; 2001 Jan; 13(1):63-73. PubMed ID: 11133835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity.
    Hsu BL; Donermeyer DL; Allen PM
    J Immunol; 1996 Sep; 157(6):2291-8. PubMed ID: 8805626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How the T cell repertoire becomes peptide and MHC specific.
    Huseby ES; White J; Crawford F; Vass T; Becker D; Pinilla C; Marrack P; Kappler JW
    Cell; 2005 Jul; 122(2):247-60. PubMed ID: 16051149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential usage of T-cell receptor V beta gene families by CD4+ and CD8+ T cells in patients with CD8hi common variable immunodeficiency: evidence of a post-thymic effect.
    Duchmann R; Jaffe J; Ehrhardt R; Alling DW; Strober W
    Immunology; 1996 Jan; 87(1):99-107. PubMed ID: 8666443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction.
    Hughes MM; Yassai M; Sedy JR; Wehrly TD; Huang CY; Kanagawa O; Gorski J; Sleckman BP
    Eur J Immunol; 2003 Jun; 33(6):1568-75. PubMed ID: 12778474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity.
    Nakajima H; Leonard WJ
    J Immunol; 1999 Jan; 162(2):782-90. PubMed ID: 9916699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities.
    Chmielowski B; Muranski P; Ignatowicz L
    J Immunol; 1999 Jan; 162(1):95-105. PubMed ID: 9886374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
    Chen W; Thoburn C; Hess AD
    J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic modulation of the TCR repertoire in the lymphoid periphery.
    Blish CA; Gallay BJ; Turk GL; Kline KM; Wheat W; Fink PJ
    J Immunol; 1999 Mar; 162(6):3131-40. PubMed ID: 10092762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Origin of a T cell clone with a mismatched combination of MHC restriction and coreceptor expression.
    Suzuki H; Eshima K; Takagaki Y; Hanaoka S; Katsuki M; Yokoyama M; Hasegawa T; Yamazaki S; Shinohara N
    J Immunol; 1994 Nov; 153(10):4496-507. PubMed ID: 7525706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity.
    Patten PA; Rock EP; Sonoda T; Fazekas de St Groth B; Jorgensen JL; Davis MM
    J Immunol; 1993 Mar; 150(6):2281-94. PubMed ID: 7680688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The orientation of a T cell receptor to its MHC class II:peptide ligands.
    Hong SC; Sant'Angelo DB; Dittel BN; Medzhitov R; Yoon ST; Waterbury PG; Janeway CA
    J Immunol; 1997 Nov; 159(9):4395-402. PubMed ID: 9379037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A common TCR beta-chain expressed by CD8+ intestinal mucosa T cells in ulcerative colitis.
    Chott A; Probert CS; Gross GG; Blumberg RS; Balk SP
    J Immunol; 1996 Apr; 156(8):3024-35. PubMed ID: 8609425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of MHC restriction by TCR Valpha CDR1 and CDR2.
    Sim BC; Zerva L; Greene MI; Gascoigne NR
    Science; 1996 Aug; 273(5277):963-6. PubMed ID: 8688082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.